What's Driving Hims & Hers Health Inc's Surprising 41% Stock Ral
After $1.6B blank-check deal, Hims & Hers plots expansion into more conditions - MedCity News
For Hims Review Is Gendered Healthcare Pointless? – Illuminate Labs
3 Top Competitors To Hims & Hers Health Inc.
Hims & Hers: A Potential 100-Bagger In the Making?
Hims & Hers Health, Inc. Reports Thir
More healthtech companies are going public, but are they measuring up?
Hims, the telehealth startup, saw its shares slip in their trading debut — and that's fine with its CEO
Hims & Hers' boost in revenues and users underscores the rise of D2C healthcare - Insider Intelligence Trends, Forecasts & Statistics
Hims Review 2024: Do Its ED Products Really Work?